EODData

NASDAQ, NTLA: Intellia Thera CS

22 May 26 15:59
LAST:

12.60

CHANGE:
 0.23
OPEN:
12.48
HIGH:
12.89
ASK:
23.56
VOLUME:
2.25M
CHG(%):
1.86
PREV:
12.37
LOW:
12.35
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
22 May 2612.4012.8912.3512.603.2M
21 May 2611.9612.4611.8212.374.44M
20 May 2611.9112.5311.7912.264.91M
19 May 2612.2712.4211.8411.945.52M
18 May 2613.7813.8812.1112.699.65M
15 May 2613.3514.1513.2413.6714.83M
14 May 2614.1614.3812.9213.0914.17M
13 May 2613.9714.5813.7514.283.76M
12 May 2614.3414.5013.5213.994.66M
11 May 2614.0615.5513.9714.427.24M

PROFILE

Name:Intellia Thera CS
About:Intellia Therapeutics, Inc., a clinical-stage gene editing company, focuses on the development of curative genome editing treatments. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 that is in Phase 1/2 study for the treatment of hereditary angioedema. It also focusses on the research of proprietary programs focused on developing engineered cell therapies to treat various cancers and autoimmune diseases. The company has license and collaboration agreement with AvenCell Therapeutics, Inc. to develop allogeneic universal CAR-T cell therapies; Kyverna Therapeutics, Inc. for the development of an allogeneic CD19 CAR-T cell therapy for the treatment of various of B cell-mediated autoimmune diseases; ONK Therapeutics, Ltd. for the development of engineered NK cell therapies to cure patients with cancer; and ReCode Therapeutics, Inc. to develop novel genomic medicines for the treatment of cystic fibrosis. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:40 Erie Street, Cambridge, MA, United States, 02139
Website:https://www.intelliatx.com
CUSIP:45826J105
CIK:0001652130
ISIN:US45826J1051
FIGI:BBG007KC7PB0
LEI:5493002T5BCPE5DZC723

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-2.49 
Forward P/E:-4.58 
PEG Ratio:0.07 
Price to Sales:25.63 
Price to Book:2.32 
Operating Margin:-7.72 
Return on Assets:-0.31 
Return on Equity:-0.57 
EPS Ratio:-3.81 
Revenue:52.86M 
Shares:118.13M 
Market Cap:1.488B 

TECHNICAL INDICATORS

MA5:12.371.8%
MA10:13.134.2%
MA20:13.285.4%
MA50:13.567.6%
MA100:13.053.6%
MA200:13.235.0%
STO9:25.00
STO14:18.28 
RSI14:40.70
WPR14:-73.39
MTM14:-0.71
ROC14:-0.05 
ATR:0.99 
Week High:14.1512.3%
Week Low:11.796.9%
Month High:16.9734.7%
Month Low:11.765.0%
Year High:28.25124.2%
Year Low:6.8384.5%
Volatility:62.57